This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 1988.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988
Title: Ram S Bhatt: Innovator in Recombinant Technology
Introduction
Ram S Bhatt is a notable inventor based in Nutley, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of recombinant growth hormone releasing factors. His innovative work has led to advancements in genetic engineering and microbial expression systems.
Latest Patents
Ram S Bhatt holds a patent for a recombinant growth hormone releasing factor. The patent describes the preparation of a double-stranded polydeoxy ribonucleotide with cohesive termini, which includes a structural gene coding for the expression of recombinant growth hormone releasing factor. The invention emphasizes the use of codons preferred for the expression of microbial genomes. Additionally, it outlines a method for producing such DNA and a recombinant microbial cloning vehicle comprising this DNA, along with novel methods for producing the peptide.
Career Highlights
Ram S Bhatt is associated with Hoffmann-La Roche Inc., where he has been instrumental in advancing research and development in biotechnology. His work has contributed to the understanding and application of recombinant DNA technology, which has far-reaching implications in medicine and agriculture.
Collaborations
Throughout his career, Ram S Bhatt has collaborated with esteemed colleagues, including Kenneth J Collier and Robert M Crowl. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.
Conclusion
Ram S Bhatt's contributions to biotechnology, particularly through his patent on recombinant growth hormone releasing factors, highlight his role as a key innovator in the field. His work continues to influence advancements in genetic engineering and microbial technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
